Supplier
Fresenius Kabi NV/SA
Schelle · BEL
Track this recordFree account — get alerted when a contract here runs out.
Awards
10
Total awarded
€3.2m
2 joint award(s) counted pro rata
Buyers
3
Sectors
2
Group: FRESENIUS KABI
Reg. BE 0458.813.760
Contracts this supplier holds that are running out
- €581,660
11 Sept 2030
stated - €306,042
11 Sept 2030
stated - €853,292
13 Sept 2030
stated - €369,562
20 Sept 2030
stated - €389,604
21 Sept 2030
stated - €820,026
21 Sept 2030
stated - €206,363
29 Nov 2030
stated - €74,073
31 Dec 2030
stated - €2,280
31 Dec 2030
stated - €8,151
31 Dec 2030
stated
Awards
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| Ropivacaïne | Universitair Ziekenhuis Gent | Fresenius Kabi NV/SA | €820,026 | 22 Sept 2026 |
| Rocuronium | Universitair Ziekenhuis Gent | Fresenius Kabi NV/SA | €369,562 | 22 Sept 2026 |
| Propofol ampul | Universitair Ziekenhuis Gent | Fresenius Kabi NV/SA | €206,363 | 22 Sept 2026 |
| Propofol flacon | Universitair Ziekenhuis Gent | Fresenius Kabi NV/SA | €389,604 | 22 Sept 2026 |
| Specifieke enterale en/of medische voeding deel E | AZ Sint-Jan Brugge AV | Fresenius Kabi NV/SA | €8,151 | 21 Sept 2026 |
| Specifieke enterale en/of medische voeding deel D | AZ Sint-Jan Brugge AV | Fresenius Kabi NV/SA | €2,280 | 21 Sept 2026 |
| Algemene enterale voeding | AZ Sint-Jan Brugge AV | Fresenius Kabi NV/SA | €74,073 | 21 Sept 2026 |
| Irinotecan IV | Hospilim VZW | ACCORD HEALTHCARE, Fresenius Kabi NV/SA | €306,042 | 17 Sept 2026 |
| Oxaliplatine IV | Hospilim VZW | ACCORD HEALTHCARE, Fresenius Kabi NV/SA | €581,660 | 17 Sept 2026 |
| Paracetamol: flacon | Universitair Ziekenhuis Gent | Fresenius Kabi NV/SA | €853,292 | 3 Sept 2026 |